Brad Camino
Analyst
Guggenheim
Equibles does not estimate personal net worth.
About Brad Camino
Brad Camino is recorded as Analyst at Guggenheim. Brad Camino has spoken on 1 investor event across 1 company, most recently for C4 Therapeutics, Inc. on June 18, 2026. The companies whose calls Brad Camino spoke on are classified in the Healthcare sector.
Brad Camino on recent calls
“The question for me is, how do you think about the ability for these next-generation IKZF1-3 degraders to be more effective than pomalidomide and earlier lines of therapy?”
Affiliation history
-
Guggenheim
Analyst
Transcript header (unverified)
Current